HOME > ARCHIVE
ARCHIVE
- BULLETIN
October 27, 2003
- DIAGNOSTIC NEWS IN BRIEF
October 27, 2003
- WEBSITE NEWS
October 27, 2003
- Most GE Houses Forecast Growth in FY2003: EPMA Survey
October 27, 2003
- <Special Contribution>
October 27, 2003
- AstraZeneca Reorganizes Primary Care Business Unit
October 20, 2003
- Korosho WG Hears 7 Bodies on Deregulation of OTC Drug Sales
October 20, 2003
- WEBSITE NEWS
October 20, 2003
- Korosho WG Discusses New "Health Food" System
October 20, 2003
- Nippon Chemiphar to Launch 1st Generic Codeveloped with Ranbaxy in 2005
October 20, 2003
- MEDICAL DEVICE NEWS IN BRIEF
October 20, 2003
- Mochida Returns Toyama Plant to Meiji Yakuhin
October 20, 2003
- Incoming Banyu President Hirate Expresses His Hopes
October 20, 2003
- BUSINESS NEWS IN BRIEF
October 20, 2003
- NEW PRODUCTS
October 20, 2003
- Osaka's ICH-6 to Discuss New GLs for Quality Systems
October 20, 2003
- NHI Prices of Original Products Should Be Cut on Entry of Generics: Dr Sakurai
October 20, 2003
- Switch OTC Drugs to Revitalize OTC Drug Market: Dr Fujii
October 20, 2003
- REGULATORY NEWS IN BRIEF
October 20, 2003
- Increased Copayment Rate Has Affected Medical Care in Nearly 60% of Patients
October 20, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
